InvestSMART

Genera Biosystems Limited (ASX: GBI) - Announcements

DELISTED - Current share price for GBI : $0.160

ASX company news and announcements for Genera Biosystems Limited (GBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genera Biosystems Limited (GBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genera Biosystems Limited (GBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genera Biosystems Limited (GBI)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Preliminary Final Report 26 Aug 2011 5:22PM $0.120 $0.160 risen by 33.33%
- Conclusion of agreement with research partner 17 Aug 2011 11:44AM $0.145 $0.160 risen by 10.34%
- Appendix 4C - quarterly 27 Jul 2011 2:08PM $0.140 $0.160 risen by 14.29%
- Business update, Outcome of Strategic Review 4 Jul 2011 9:01AM $0.180 $0.160 fallen by 11.11%
- Appendix 4C - quarterly 29 Apr 2011 2:00PM $0.230 $0.160 fallen by 30.43%
- Rights Issue closure and shortfall, Proposed Option Issue 1 Apr 2011 2:18PM $0.280 $0.160 fallen by 42.86%
- Grant of Key US Patent 23 Mar 2011 3:25PM $0.280 $0.160 fallen by 42.86%
- Further milestone payment received from partner 21 Mar 2011 3:45PM $0.280 $0.160 fallen by 42.86%
- Non-renounceable rights issue documents 28 Feb 2011 9:17AM $0.320 $0.160 fallen by 50%
- Half Yearly Report and Accounts 24 Feb 2011 5:03PM $0.240 $0.160 fallen by 33.33%
- Commercialisation Update, Capital Raising Update 23 Feb 2011 9:54AM $0.390 $0.160 fallen by 58.97%
- Trading Halt 21 Feb 2011 9:34AM $0.410 $0.160 fallen by 60.98%
- Appendix 4C - quarterly 31 Jan 2011 4:47PM $0.470 $0.160 fallen by 65.96%
- Milestone payment received from partner 6 Jan 2011 10:09AM $0.450 $0.160 fallen by 64.44%
- Chairman`s Address to Shareholders 25 Nov 2010 10:52AM $0.410 $0.160 fallen by 60.98%
- Appendix 4C - quarterly 29 Oct 2010 5:43PM $0.410 $0.160 fallen by 60.98%
- Appendix 4E Preliminary Final Report 30 Aug 2010 4:34PM $0.470 $0.160 fallen by 65.96%
- Appendix 4C - quarterly 23 Jul 2010 6:25PM $0.470 $0.160 fallen by 65.96%
- GBI Major R and D Alliance with Top 10 Diagnostic Company 24 May 2010 9:22AM $0.590 $0.160 fallen by 72.88%
- GBI agreement with HSP on novel respiratory pathen test 11 May 2010 9:24AM $0.650 $0.160 fallen by 75.38%
- Appendix 4C - quarterly 30 Apr 2010 4:17PM $0.610 $0.160 fallen by 73.77%
- Genera CE Marks PapType Product 19 Apr 2010 10:04AM $0.685 $0.160 fallen by 76.64%
- Appendix 4D Half Yearly Report and Accounts 18 Feb 2010 4:00PM $0.780 $0.160 fallen by 79.49%
- Appendix 4C - quarterly 29 Jan 2010 4:37PM $0.755 $0.160 fallen by 78.81%
- Regulatory Notice on PapType at end of Trading Halt period 22 Jan 2010 9:32AM $0.800 $0.160 fallen by 80%

226 - 250 of 275 results

Page 10 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.